Hair loss affects a remarkable number of people, including both men and women. Male pattern baldness can affect men as early as in their 20s with hair loss worsening as they get older. Women may experience hair loss for a variety of reasons, including hormone fluctuations, medications, and stress. Considering the widespread prevalence, it’s no wonder why the global hair restoration industry is seeing such significant growth. In 2017, there was a rapid 67% increase from the previous year in patients seeking a solution to hair loss, with over 1.8 million people worldwide turning to either surgical or non-surgical procedures (ISHRS, 2017).
The hair loss market is large and complex, but most importantly, it is different for all patients. With the right hair restoration treatment, you can target patients with hair loss to help restore their natural hairline. While traditional transplant procedures are invasive, leave a linear scar, and incur significant downtime, Venus Concept’s hair loss solutions leave no visible linear scar, are minimally invasive, and patients can return to their routine within the same week.
We combined next-generation surgical techniques with decades of data to improve every detail of the hair restoration procedure for both the doctor and the patient: a touchscreen interface, an articulated workstation, new recipient site creation handpiece, and a more efficient pneumatic motor. NeoGraft® 2.0 is designed to be more than a device—it’s engineered to make us partners for optimal aesthetic success.
ARTAS iX™ is the world’s only comprehensive and intelligent hair restoration system combining robotics and AI to deliver natural-looking, personalized results with extreme precision and repeatability. The innovative system leverages state-of-the-art technology to enable accurate and efficient harvesting, recipient site-making, and implantation functionality in one device.
Improve thinning on the top and front of the scalp for hair that appears thicker and fuller.
Results after: 1 treatment
Graft Count: 1,200
INDICATIONS FOR USE:
NeoGraft® has CE Mark with indication for use in suction-assisted follicular extraction and re-implantation. NeoGraft® is an auto-graft system and can be used on both male and female patients.
ARTAS iX™ has CE Mark with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
1. U.S. National Library of Medicine. Androgenetic alopecia. (n.d.). Retrieved from https://ghr.nlm.nih.gov/condition/androgenetic-alopecia#statistics
2. American Hair Loss Association. (n.d.). Retrieved from https://www.americanhairloss.org/men_hair_loss/introduction.html.
3. Research And Markets. Male Aesthetics: Global Industry Analysis, Trends, Market Size and Forecasts to 2024 - ResearchAndMarkets.com [Press release]. (2018, September 21). Retrieved from